{
    "prompt": "Please provide each treatment as a json format with the following JSON schema.\n    {\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\":\n            \"Link to FDA-approved Label\": \n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0018760\nAge: 30\nGender: Female\nSample ID: P-0018760-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Rectal Adenocarcinoma\nSample Type: Primary\nTumor Purity: 20.0%\n=============\nDNA Variants:\nAPC c.1690C>T (p.R564*) - in 17.00% of 197 reads\nERBB4 c.836T>G (p.F279C) - in 8.00% of 237 reads\nPTPRS c.2566G>T (p.A856S) - in 18.00% of 573 reads\nTP53 c.527G>T (p.C176F) - in 11.00% of 646 reads\nTP53 c.702C>G (p.Y234*) - in 25.00% of 638 reads\nCNA Data:\nERBB2 - High Level Amplification\nCDK12 - High Level Amplification\nRARA - High Level Amplification\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Treatment 1\": {\n    \"Disease Name\": \"Rectal Adenocarcinoma\",\n    \"Disease Phase or Condition\": \"Primary\",\n    \"Drug Name\": \"Trastuzumab (Herceptin)\",\n    \"Prior Treatment or Resistance Status\": \"No prior treatment specified\",\n    \"Genomic Features\": \"ERBB2 high level amplification\",\n    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125409s092lbl.pdf\"\n  },\n  \"Treatment 2\": {\n    \"Disease Name\": \"Rectal Adenocarcinoma\",\n    \"Disease Phase or Condition\": \"Primary\",\n    \"Drug Name\": \"PARP inhibitors (e.g., Olaparib)\",\n    \"Prior Treatment or Resistance Status\": \"No prior treatment specified\",\n    \"Genomic Features\": \"CDK12 high level amplification\",\n    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208070s003lbl.pdf\"\n  }\n}"
}